Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.5 EUR -11.19% Market Closed
Market Cap: 20.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Revenue Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Revenue
€72k
CAGR 3-Years
N/A
CAGR 5-Years
-34%
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Revenue
$119.9m
CAGR 3-Years
84%
CAGR 5-Years
40%
CAGR 10-Years
26%
Galapagos NV
AEX:GLPG
Revenue
€580.3m
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Revenue
€263k
CAGR 3-Years
-50%
CAGR 5-Years
-45%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Revenue?
Revenue
72k EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Revenue amounts to 72k EUR.

What is Celyad Oncology SA's Revenue growth rate?
Revenue CAGR 5Y
-34%

Over the last year, the Revenue growth was 64%.

Back to Top